Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin
Ihr Browser zeigt an, ob sie diesen Verweis schon einmal besucht haben.
Jaime Felipe Guerrero-Garzón (Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna); Eva Madland (NOBIPOL, Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology); Martin Zehl (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna); Madhurendra Singh (Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet); Shiva Rezaei (Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet); Finn L. Aachmann (NOBIPOL, Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology); Gaston Courtade (NOBIPOL, Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology); Ernst Urban (Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna); Christian Rückert (Center for Biotechnology, Bielefeld University); Tobias Busche (Center for Biotechnology, Bielefeld University); Jörn Kalinowski (Center for Biotechnology, Bielefeld University); Yan-Ru Cao (Yunnan Institute of Microbiology, Yunnan University); Yi Jiang (Yunnan Institute of Microbiology, Yunnan University); Cheng-lin Jiang (Yunnan Institute of Microbiology, Yunnan University); Galina Selivanova (Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet); Sergey B. Zotchev (Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna)
–
2020